Boundless Bio
Discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. Learn more
Launch date
Employees
Market cap
$79.9m
Enterprise valuation
($99m) (Public information from Sep 2024)
Share price
$4.27 BOLD
San Diego California (HQ)
Authorizing premium user...